Celecoxib
Celebrex, Elyxyb (celecoxib) is a small molecule pharmaceutical. Celecoxib was first approved as Celebrex on 1998-12-31. It is used to treat adenomatous polyposis coli, ankylosing spondylitis, dysmenorrhea, osteoarthritis, and rheumatoid arthritis in the USA. The pharmaceutical is active against prostaglandin G/H synthase 2. In addition, it is known to target carbonic anhydrase 12, prostaglandin G/H synthase 1, and carbonic anhydrase 2. Celebrex's patent is valid until 2036-05-27 (FDA).
| Trade Name | Celebrex, Elyxyb |
|---|---|
| Common Name | Celecoxib |
| Indication | adenomatous polyposis coli, ankylosing spondylitis, dysmenorrhea, osteoarthritis, rheumatoid arthritis |
| Drug Class | Cyclooxygenase-2 inhibitors |
